Atlas FDA

SYNVISC and SYNVISC ONE

FDA premarket approval P940015/S047 · decided 2021-10-27

Approval details

PMA number
P940015
Supplement
S047
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
SYNVISC and SYNVISC ONE
Generic name
Acid, hyaluronic, intraarticular
Applicant
Sanofi Genzyme Corp.
Date received
2021-04-30
Decision date
2021-10-27
Days to decision
180 days
Decision code
APPR
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Cambridge, MA
Statement
Approval for the use of existing filling and parts washing machines to manufacture a biologic when not in use for the manufacture of Synvisc and Synvisc-One.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.